On the contrary, a tumor suppressive role of NFAT1 was proposed in DLBCL where its downregulation correlated with increased cyclin E expression; specifically, NFAT1 directly controlled cyclin E induction by binding to its promoter in lymphoma cell lines (36). The gene discussed is NFATC2; the disease is neoplasm.